Written for a composite rural practice, the NU553 Unit 9 policy paper sets out DEA schedules and registration, then state rules left as [State] placeholders, then the clinic's own procedures. Searches like "nu 553 unit 9 assignment example", "nu553 unit 9 sample" and "nu553 unit 9 example" land here.
What a finished NU553 Unit 9 controlled substance policy paper looks like
Five pages in the form of a practice policy with a rationale beneath each section. Section one summarizes the Controlled Substances Act of 1970 and its five schedules, and states that prescribing from Schedules II through V requires a DEA registration for the state of practice. Section two covers what the federal rules add for Schedule II: no refills, and the option since 2007 of issuing several prescriptions at once covering up to [90] days. Section three is a set of placeholders, [State] rules on nurse practitioner authority for each schedule, collaboration requirements, and when the state prescription monitoring database must be checked, each with the board or statute to consult. Section four sets clinic procedure: treatment agreements, urine drug testing as a clinical tool, naloxone offered with opioid prescriptions, and storage and disposal teaching.
How a NU553 Unit 9 example is structured
The paper's organizing principle is jurisdiction. Federal requirements are stated as facts with citations because they apply in every state; state requirements are left as bracketed placeholders because they vary, and the paper names where each answer would be found rather than guessing it. That split is typically what graders look for first. Each policy statement has a rationale beneath it, linking the rule to the harm it addresses, so the policy reads as reasoning and not as a checklist copied from a template. Clinical guidance is dated: the 2022 CDC guideline on opioids for pain is cited for starting doses, reassessment and naloxone, and described as guidance rather than law. A final section addresses the two federal changes of 2023, the removal of the separate buprenorphine waiver and the one-time training requirement for DEA registrants.
Five schedules, one registration
The Controlled Substances Act sorts drugs by accepted medical use and potential for misuse. The paper gives the logic of the schedules instead of long lists, and ties prescribing authority to a DEA registration held for the state where the prescriber practices.
What Schedule II adds
No refills are permitted, and since a 2007 DEA rule a prescriber may issue several prescriptions at one visit for up to a [90]-day supply, each dated for filling. The policy states when the clinic will use that option.
The state sections left blank on purpose
Nurse practitioner authority for Schedule II, collaboration terms and monitoring database rules differ by state. Each appears as [State] with the statute or board rule to consult, which is more accurate than a confident national answer.
Clinic procedure with its reasons
Treatment agreements, periodic urine testing, naloxone offered with each opioid prescription and teaching on locked storage and take-back disposal each carry a sentence naming the harm the step is meant to prevent.
Two changes from 2023
The separate federal waiver to prescribe buprenorphine for opioid use disorder ended in January 2023, and registrants now complete a one-time eight hours of substance use training. Both are cited to the laws that made them.
Where marks go in NU553 Unit 9
The line between federal and state law is watched more closely than anything else on this paper. A policy that states one national rule for nurse practitioner authority over Schedule II drugs, or for checking the monitoring database, is wrong somewhere, and assuming the case's state without saying so costs heavily. Federal facts stated without citation read as hearsay; the 2007 multiple-prescription rule and the 2023 changes are where dates matter. Treating the CDC guideline as law is a frequent confusion and is marked. Policies with no rationale beneath their rules look copied, even when every rule is correct. Mentioning the buprenorphine waiver as a current requirement dates the paper by several years. Examples placed in the wrong schedule draw a correction, and so does naloxone mentioned without saying when it is offered.
Get a NU553 Unit 9 example written to your instructions
Include the [State] your NU553 Unit 9 prompt specifies, or say that it leaves the choice open, along with the drug classes involved and the rubric. At no cost for a first request and within 24-48h, the sample policy separates federal facts from state placeholders, dates every rule and puts a rationale beneath each one.
NU553 Unit 9 questions, answered
Can the paper assume the rules of the state where I plan to practice?
Yes, where the prompt leaves the state open, but name it and cite the nursing board rule or statute behind every state-level requirement. The sample leaves [State] as a placeholder because authority over Schedule II drugs, collaboration terms and monitoring database requirements vary widely. A paper that picks a state and documents it is stronger than one that implies a national standard.
Is the CDC opioid guideline legally binding?
No. The 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain is voluntary clinical guidance, and the document itself says it should not be applied as inflexible policy. Some states have written their own limits into law, which are binding. The stronger papers keep the two categories apart and cite each accordingly.
Should the policy cover stimulants and benzodiazepines too?
That depends on the prompt. The sample focuses on opioids for chronic pain because the case does, but the same structure, federal rule, state placeholder and clinic procedure, works for any scheduled class. Benzodiazepines are Schedule IV and most stimulants Schedule II, so the refill rules differ, and a broader policy should say so class by class.